Research pen
Thymosin Beta-4 synthetic peptide fragment
TB-500 (Thymosin Beta-4) is a synthetic peptide fragment commonly utilised in laboratory research involving peptide structure, actin-associated pathways, and cellular signalling systems.
For laboratory and research use only. Pen illustration is a visual reference. Confirm the supplied format and batch details with our team.
TB-500 Pen, 5 mg selected.
A complete reference
TB-500 (Thymosin Beta-4) is a synthetic peptide fragment commonly utilised in laboratory research involving peptide structure, actin-associated pathways, and cellular signalling systems.
TB-500 is a synthetic analogue of the naturally occurring protein Thymosin Beta-4. In controlled research environments, it is used as a model compound in studies involving peptide interactions, actin-related processes, and experimental biological systems.
Chemical reference information: CAS number: 77591-33-4; Molecular formula: C₂₁₂H₃₅₀N₅₆O₇₈S; Molecular weight: 4963.4 g/mol. These reference identifiers describe the formulation; the batch-specific analytical record identifies the supplied material.
Reference conditions for unreconstituted research material are −20°C with moisture and direct light excluded. Use the storage instructions on the supplied batch record for the actual presentation, and record any change of physical state or storage conditions.
Where laboratory preparation is required, use an appropriate validated solvent and aseptic peptide-handling procedure. Solvent compatibility, final concentration, and post-preparation storage depend on the specific formulation and experimental protocol. The catalog strength is the compound amount, not the concentration of a prepared solution.
NORVEXA Bioscience batch documentation can be requested using the printed reference and lot number. Review identity, analytical purity, presentation, and handling specifications before including a material in a laboratory workflow.
TB-500 5 mg is offered as a NORVEXA research pen. The selected strength refers to the compound content of this pen reference. Request the matching batch record for identity, analytical specifications, and presentation details.
Reference conditions for unreconstituted research material are −20°C with moisture and direct light excluded. Use the storage instructions on the supplied batch record for the actual presentation, and record any change of physical state or storage conditions.
Where laboratory preparation is required, use an appropriate validated solvent and aseptic peptide-handling procedure. Solvent compatibility, final concentration, and post-preparation storage depend on the specific formulation and experimental protocol. The catalog strength is the compound amount, not the concentration of a prepared solution.
NORVEXA Bioscience batch documentation can be requested using the printed reference and lot number. Review identity, analytical purity, presentation, and handling specifications before including a material in a laboratory workflow.
Include the printed batch reference when requesting your certificate of analysis. The record applies to the batch supplied to your laboratory.
Prepare a documentation requestContinue exploring
10 mg / 50 mg
5-Amino-1MQ (5-Amino-1-methylquinolinium iodide) is a small molecule compound identified in scientific literature as an inhibitor of nicotinamide N-methyltransferase (NNMT), an enzyme involved in cellular metabolic pathways. NORVEXA research pen format.
Reference details
10 mg
ARA-290 (Cibinetide) is a synthetic peptide derived from the helix B domain of erythropoietin (EPO). NORVEXA research pen format.
Reference details
5 mg
AOD-9604 (Growth Hormone Fragment 177–191) is a synthetic peptide derived from the C-terminal region of human growth hormone. NORVEXA research pen format.
Reference details